Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-12
DOI
10.1038/s41598-018-32159-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2018
- (2018) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer
- (2017) Alvin P Makohon-Moore et al. NATURE GENETICS
- Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis
- (2017) Oliver G McDonald et al. NATURE GENETICS
- BLIMP1 Induces Transient Metastatic Heterogeneity in Pancreatic Cancer
- (2017) Shin-Heng Chiou et al. Cancer Discovery
- miRNA-101 Suppresses Epithelial-to-mesenchymal Transition by Targeting HMGA2 in Pancreatic Cancer Cells
- (2016) Wenli Jiang et al. Anti-Cancer Agents in Medicinal Chemistry
- Hmga2 is dispensable for cutaneous squamous cell carcinoma
- (2016) Andrew White et al. EXPERIMENTAL DERMATOLOGY
- Genetic Diversity of Pancreatic Ductal Adenocarcinoma and Opportunities for Precision Medicine
- (2016) Erik S. Knudsen et al. GASTROENTEROLOGY
- Genetics and biology of pancreatic ductal adenocarcinoma
- (2016) Haoqiang Ying et al. GENES & DEVELOPMENT
- Modeling Therapy Response and Spatial Tissue Distribution of Erlotinib in Pancreatic Cancer
- (2016) B. M. Gru ner et al. MOLECULAR CANCER THERAPEUTICS
- An in vivo multiplexed small-molecule screening platform
- (2016) Barbara M Grüner et al. NATURE METHODS
- Pancreatic cancer
- (2016) Jorg Kleeff et al. Nature Reviews Disease Primers
- RUNX3 Controls a Metastatic Switch in Pancreatic Ductal Adenocarcinoma
- (2015) Martin C. Whittle et al. CELL
- Gemcitabine resistance in pancreatic ductal adenocarcinoma
- (2015) Yoav Binenbaum et al. DRUG RESISTANCE UPDATES
- Whole genomes redefine the mutational landscape of pancreatic cancer
- (2015) Nicola Waddell et al. NATURE
- Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma
- (2015) Richard A Moffitt et al. NATURE GENETICS
- Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma
- (2015) Pawel K Mazur et al. NATURE MEDICINE
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- Epigenetics and pancreatic cancer: Pathophysiology and novel treatment aspects
- (2014) Daniel Neureiter WORLD JOURNAL OF GASTROENTEROLOGY
- A Conditional System to Specifically Link Disruption of Protein-Coding Function with Reporter Expression in Mice
- (2014) Shin-Heng Chiou et al. Cell Reports
- HMGA2 Is a Driver of Tumor Metastasis
- (2013) A. Morishita et al. CANCER RESEARCH
- Transcriptome Profiling Identifies HMGA2 as a Biomarker of Melanoma Progression and Prognosis
- (2013) Leon Raskin et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Three-Dimensional Collagen I Promotes Gemcitabine Resistance In Vitro in Pancreatic Cancer Cells through HMGA2-Dependent Histone Acetyltransferase Expression
- (2013) Surabhi Dangi-Garimella et al. PLoS One
- HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis
- (2013) M. Sun et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EGF Receptor Is Required for KRAS-Induced Pancreatic Tumorigenesis
- (2012) Christine M. Ardito et al. CANCER CELL
- HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma
- (2012) Salvatore Piscuoglio et al. HISTOPATHOLOGY
- Adjuvant and neoadjuvant treatment in pancreatic cancer
- (2012) Marta Herreros-Villanueva WORLD JOURNAL OF GASTROENTEROLOGY
- Overexpression of HMGA2 Promotes Metastasis and Impacts Survival of Colorectal Cancers
- (2011) X. Wang et al. CLINICAL CANCER RESEARCH
- Suppression of lung adenocarcinoma progression by Nkx2-1
- (2011) Monte M. Winslow et al. NATURE
- Distant metastasis occurs late during the genetic evolution of pancreatic cancer
- (2010) Shinichi Yachida et al. NATURE
- Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinoma
- (2010) P. K. Mazur et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HMGA2 Maintains Oncogenic RAS-Induced Epithelial-Mesenchymal Transition in Human Pancreatic Cancer Cells
- (2009) Sugiko Watanabe et al. AMERICAN JOURNAL OF PATHOLOGY
- A robust and high-throughput Cre reporting and characterization system for the whole mouse brain
- (2009) Linda Madisen et al. NATURE NEUROSCIENCE
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- The High Mobility Group Protein HMGA2: A Co-Regulator of Chromatin Structure and Pluripotency in Stem Cells?
- (2009) Kurt Pfannkuche et al. Stem Cell Reviews and Reports
- Clinical Significance of High Mobility Group A2 in Human Gastric Cancer and Its Relationship to let-7 MicroRNA Family
- (2008) K. Motoyama et al. CLINICAL CANCER RESEARCH
- HMGA2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinoma
- (2008) Alexandra C Hristov et al. MODERN PATHOLOGY
- HMGA2 Participates in Transformation in Human Lung Cancer
- (2008) F. Di Cello et al. MOLECULAR CANCER RESEARCH
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
- (2008) S. Jones et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search